Our study showed that the expression of AR protein in injured BMVECs after cerebral ischemia was significantly increased, and the use of epalrestat could reduce the expression of AR and effectively improve the function of BMVECs, indicating that inhibition of overproduced AR may be a key strategy to alleviate BBB injury after cerebral ischemia. Here, AR is linked to brain ischemia.